https://www.selleckchem.com/products/pco371.html
These functional effects highlight a cooperative down-modulation of MYCN and its down-stream targets, ALK and LIN28B, exerted by miR-34a and let-7b that reactivate regulatory networks leading to a favorable therapeutic response. These findings demonstrate a promising therapeutic efficacy of miR-34a and let-7b combined replacement and support its clinical application as adjuvant therapy for high-risk NB patients. © 2020 WILEY-VCH Verlag GmbH Co. KGaA, Weinheim.Concomitant chemo-radiotherapy (cCRT) with 60 Gy in 30 fractions is the s
Like
Comment
Share
